This inventory table displays a summary of the number of cases for each disease site (collection site) and sample type, not the total number of specimens available. Cases are defined by the number of collection events associated with a single donor.

The inventory numbers are updated and represent current availability not total accrual. Collection site refers to location of the tissue sample.

Additional selection criteria, such as specific histologic types for a disease site, may reduce the number of available cases.

Please Contact Us () for additional information.

Georgia Cancer Center Biorepository Inventory Summary
Anatomic Site / Collection Site / Number of Available Cases by Specimen Type
Fresh Frozen Tissue / Blood Derivatives
Tumor* / Normal / Serum / Plasma / Buffy Coat / MNC
Hematologic
malignancies
Nervous System
CNS, Brain and Peripheral / 84 / 1 / 121 / 111 / 106 / 1
Gastrointestinal
Anal / 0 / 0 / 2 / 2 / 2 / 0
Colorectal / 82 / 107 / 139 / 92 / 89 / 0
Esophageal / 8 / 10 / 12 / 6 / 6 / 0
Gallbladder / 4 / 6 / 6 / 7 / 7 / 0
Gastric / 21 / 14 / 33 / 25 / 25 / 0
Hepatic, Biliary Tree / 67 / 45 / 82 / 57 / 54 / 0
Pancreatic / 30 / 13 / 52 / 46 / 46 / 0
Small Intestine / 9 / 17 / 5 / 5 / 5 / 0
Endocrine
Endocrine: Parathyroid, Adrenal, Thyroid / 242 / 63 / 400 / 369 / 366 / 0
Skin
Melanoma / 3 / 1 / 35 / 25 / 26 / 0
Skin-Non Melanomas / 18 / 12 / 50 / 46 / 45 / 0
Lung and Thoracic
Lung / 81 / 62 / 120 / 85 / 82 / 0
Thoracic, Other / 5 / 1 / 27 / 22 / 22 / 0
Thymus / 8 / 2 / 12 / 8 / 8 / 0
Breast
Breast / 86 / 79 / 294 / 393 / 384 / 0
Genitourinary
Bladder / 40 / 30 / 129 / 95 / 95 / 0
Renal and Ureter / 91 / 88 / 127 / 98 / 96 / 1
Testicular / 2 / 3 / 12 / 9 / 9 / 0
Urethral, Penile / 2 / 0 / 13 / 11 / 11 / 0
Tumor* / Normal / Serum / Plasma / Buffy Coat / MNC
Hematologic
malignancies
Prostate
(108)* / 8 / 168 / 110 / 108 / 0
Gynecologic
Cervical / 11 / 5 / 6 / 7 / 7 / 0
Endometrial / 12 / 20 / 2 / 2 / 2 / 0
Gynecologic: other / 44 / 6 / 18 / 18 / 17 / 0
Ovarian, Fallopian / 67 / 27 / 16 / 15 / 14 / 0
Uterine / 35 / 19 / 21 / 20 / 22 / 0
Vulva, Vagina / 8 / 1 / 3 / 3 / 3 / 0
Head and Neck
Larynx and Hypopharynx / 10 / 2 / 36 / 37 / 37 / 0
Nasal Cavity, Sinuses, Nasopharynx, Oral Cavity, Oropharynx / 16 / 5 / 54 / 57 / 56 / 0
Salivary Glands, Paraglangliomas / 8 / 4 / 28 / 26 / 27 / 0
Other and unknown / 42 / 8 / 147 / 151 / 150 / 0
Hematologic
Acute Lymphocytic Leukemia / 0 / 0 / 0 / 7 / 0 / 12
Acute Myelogenous Leukemia / 0 / 0 / 0 / 176 / 0 / 273
Chronic Lymphocytic Leukemia / 0 / 0 / 0 / 39 / 0 / 47
Chronic Myelogenous Leukemia / 0 / 0 / 0 / 61 / 0 / 81
Cutaneous T-Cell Lymphoma / 0 / 0 / 1 / 3 / 1 / 5
Hematopoietic disorders, MGUS, MDS, other / 0 / 0 / 0 / 236 / 9 / 347
Leukemias / 0 / 0 / 2 / 83 / 0 / 109
Lymphomas: Hodgkin, Non-Hodgkin / 1 / 0 / 12 / 139 / 9 / 195
Mantle Cell Lymphoma / 0 / 0 / 0 / 10 / 0 / 10
Multiple Myeloma / 0 / 0 / 0 / 217 / 4 / 292
Other
Gross Metastatic Disease / 0 / 0 / 0 / 0 / 0 / 0
Lymp node / 64 / 4 / 41 / 34 / 33 / 5
Other (Spleen) / 16 / 19 / 26 / 23 / 19 / 6
Pediatric Tumors / 2 / 0 / 0 / 0 / 0 / 0
Sarcomas of Bone / 0 / 0 / 0 / 0 / 0 / 0
Soft Tissue Sarcoma / 14 / 3 / 13 / 11 / 11 / 0
To be determined / 41 / 13 / 178 / 263 / 213 / 88
Unknown origin / 3 / 1 / 57 / 62 / 53 / 17

* Prostate tissue: tumor content varies significantly (please see description of the QC process)